Return to work following diagnosis of low-grade glioma: A nationwide matched cohort study. (18th August 2020)

• Record Type: Journal Article
• Authors: Rydén, Isabelle; Carstam, Louise; Gulati, Sasha; Smits, Anja; Sunnerhagen, Katharina S.; Hellström, Per; Henriksson, Roger; Bartek, Jiri; Salvesen, Øyvind; Jakola, Asgeir Store
• Is Part Of: Neurology. Volume 95:Number 7(2020)
• Publication Date: 2020-08-18
• Subjects: Neurology -- Periodicals; Neurology -- Periodicals; Neurologie -- Périodiques; 616.8
• DOI: 10.1212/WNL.0000000000009982
• Languages: English
• ISSNs: 0028-3878

Abstract

Abstract : Objective: Return-to-work (RTW) following diagnosis of infiltrative low-grade gliomas is unknown. Methods: Swedish patients with histopathologic verified WHO grade II diffuse glioma diagnosed between 2005 and 2015 were included. Data were acquired from several Swedish registries. A total of 381 patients aged 18–60 were eligible. A matched control population (n = 1, 900) was acquired. Individual data on sick leave, compensations, comorbidity, and treatments assigned were assessed. Predictors were explored using multivariable logistic regression. Results: One year before surgery/index date, 88% of cases were working, compared to 91% of controls. The proportion of controls working remained constant, while patients had a rapid increase in sick leave approximately 6 months prior to surgery. After 1 and 2 years, respectively, 52% and 63% of the patients were working. Predictors for no RTW after 1 year were previous sick leave (odds ratio [OR] 0.92, 95% confidence interval [CI] 0.88–0.96, p < 0.001), older age (OR 0.96, 95% CI 0.94–0.99, p = 0.005), and lower functional level (OR 0.64 95% CI, 0.45–0.91 p = 0.01). Patients receiving adjuvant treatment were less likely to RTW within the first year. At 2 years, biopsy (as opposed to resection), female sex, and comorbidity were also unfavorable, while age and adjuvant treatment were no longer significant. Conclusions: Approximately half of patients RTW within the first year. Lower functional status, previous sick leave, older age, and adjuvant treatment were risk factors for no RTW at 1 year after surgery. Female sex, comorbidity, and biopsy only were also unfavorable for RTW at 2 years.